3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline

C200H151N21O2 — CID 160531607

IUPAC3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline
SMILESCC1(C)c2ccccc2N(c2cc(N(c3ccc(-c4ccncc4)cc3)c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cc(N3c4ccccc4C(C)(C)c4ccccc43)c2)c2ccccc21.Cc1cc2c3cc(C)c(C)cc3n(-c3cc(N(c4ccc(-c5ccncc5)cc4)c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)cc(-n4c5cc(C)c(C)cc5c5cc(C)c(C)cc54)c3)c2cc1C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(N(c4ccc(-c5ccncc5)cc4)c4cc(N5c6ccccc6Oc6ccccc65)cc(N5c6ccccc6Oc6ccccc65)c4)cc3)n2)cc1
InChIInChI=1S/C70H57N7.C68H53N7.C62H41N7O2/c1-42-31-60-61-32-43(2)47(6)36-65(61)76(64(60)35-46(42)5)58-39-57(40-59(41-58)77-66-37-48(7)44(3)33-62(66)63-34-45(4)49(8)38-67(63)77)75(55-23-19-50(20-24-55)51-27-29-71-30-28-51)56-25-21-54(22-26-56)70-73-68(52-15-11-9-12-16-52)72-69(74-70)53-17-13-10-14-18-53;1-67(2)56-23-11-15-27-60(56)74(61-28-16-12-24-57(61)67)54-43-53(44-55(45-54)75-62-29-17-13-25-58(62)68(3,4)59-26-14-18-30-63(59)75)73(51-35-31-46(32-36-51)47-39-41-69-42-40-47)52-37-33-50(34-38-52)66-71-64(48-19-7-5-8-20-48)70-65(72-66)49-21-9-6-10-22-49;1-3-15-44(16-4-1)60-64-61(45-17-5-2-6-18-45)66-62(65-60)46-29-33-48(34-30-46)67(47-31-27-42(28-32-47)43-35-37-63-38-36-43)49-39-50(68-52-19-7-11-23-56(52)70-57-24-12-8-20-53(57)68)41-51(40-49)69-54-21-9-13-25-58(54)71-59-26-14-10-22-55(59)69/h9-41H,1-8H3;5-45H,1-4H3;1-41H
InChIKeyQVPQQXHIFIULSC-UHFFFAOYSA-N
MW2880.55 g/mol
LogP52.24
Rot. Bonds27

About 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline

3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline (PubChem CID 160531607) has the molecular formula C200H151N21O2 and a molecular weight of 2880.55 g/mol. Its IUPAC name is 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline.

Molecular Properties

Compound Name3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline
PubChem CID160531607
Molecular FormulaC200H151N21O2
Molecular Weight2880.55 g/mol
Exact Mass2878.24
IUPAC Name3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline
SMILESCC1(C)c2ccccc2N(c2cc(N(c3ccc(-c4ccncc4)cc3)c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cc(N3c4ccccc4C(C)(C)c4ccccc43)c2)c2ccccc21.Cc1cc2c3cc(C)c(C)cc3n(-c3cc(N(c4ccc(-c5ccncc5)cc4)c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)cc(-n4c5cc(C)c(C)cc5c5cc(C)c(C)cc54)c3)c2cc1C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(N(c4ccc(-c5ccncc5)cc4)c4cc(N5c6ccccc6Oc6ccccc65)cc(N5c6ccccc6Oc6ccccc65)c4)cc3)n2)cc1
InChIInChI=1S/C70H57N7.C68H53N7.C62H41N7O2/c1-42-31-60-61-32-43(2)47(6)36-65(61)76(64(60)35-46(42)5)58-39-57(40-59(41-58)77-66-37-48(7)44(3)33-62(66)63-34-45(4)49(8)38-67(63)77)75(55-23-19-50(20-24-55)51-27-29-71-30-28-51)56-25-21-54(22-26-56)70-73-68(52-15-11-9-12-16-52)72-69(74-70)53-17-13-10-14-18-53;1-67(2)56-23-11-15-27-60(56)74(61-28-16-12-24-57(61)67)54-43-53(44-55(45-54)75-62-29-17-13-25-58(62)68(3,4)59-26-14-18-30-63(59)75)73(51-35-31-46(32-36-51)47-39-41-69-42-40-47)52-37-33-50(34-38-52)66-71-64(48-19-7-5-8-20-48)70-65(72-66)49-21-9-6-10-22-49;1-3-15-44(16-4-1)60-64-61(45-17-5-2-6-18-45)66-62(65-60)46-29-33-48(34-30-46)67(47-31-27-42(28-32-47)43-35-37-63-38-36-43)49-39-50(68-52-19-7-11-23-56(52)70-57-24-12-8-20-53(57)68)41-51(40-49)69-54-21-9-13-25-58(54)71-59-26-14-10-22-55(59)69/h9-41H,1-8H3;5-45H,1-4H3;1-41H
InChIKeyQVPQQXHIFIULSC-UHFFFAOYSA-N
XLogP52.24
TPSA205.68 Ų
H-Bond Donors
H-Bond Acceptors23
Rotatable Bonds27
Heavy Atoms223
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002880.55
LogP ≤ 552.24
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1023

Analyze 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

10-[4-[4,6-bis[4-(9,9-dimethylacridin-10-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]phenoxazine
CID 118528556
10-[3-(9,9-dimethylacridin-10-yl)-5-[4-phenyl-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethylacridine
CID 118528452
10-[9-[3-carbazol-9-yl-5-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]carbazol-3-yl]-9,9-dimethylacridine
CID 168836599
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethylacridine
CID 118528441
2,6-di(phenoxazin-10-yl)-N,N-bis(4-pyridin-4-ylphenyl)pyridin-4-amine
CID 154990017
4,6-bis(3,6-dimethoxycarbazol-9-yl)-N,N-bis(4-pyridin-4-ylphenyl)-1,3,5-triazin-2-amine;4,6-bis(9,9-dimethylacridin-10-yl)-N,N-bis(4-pyridin-4-ylphenyl)-1,3,5-triazin-2-amine;4,6-di(phenoxazin-10-yl)-N,N-bis(4-pyridin-4-ylphenyl)-1,3,5-triazin-2-amine
CID 167544053
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]phenyl]-9,9-dimethylacridine
CID 118528442
3-[7-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-dimethyl-10-phenylacridin-2-yl]-10-phenylphenoxazine
CID 134579019
4-(9,9-dimethyl-10-phenylacridin-3-yl)-N,N-diphenylaniline
CID 121258967
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[4-[4-(4-phenothiazin-10-ylphenyl)-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[3-phenothiazin-10-yl-5-(6-phenyl-2-pyridinyl)phenyl]phenothiazine
CID 158999619
4-[4-(14,14-dimethyl-8-oxa-1-azapentacyclo[11.7.1.02,7.09,21.015,20]henicosa-2,4,6,9,11,13(21),15(20),16,18-nonaen-18-yl)phenyl]-N,N-diphenylaniline
CID 170656809
14,14-dimethyl-N,N-bis(4-phenylphenyl)-8-oxa-1-azapentacyclo[11.7.1.02,7.09,21.015,20]henicosa-2,4,6,9,11,13(21),15(20),16,18-nonaen-18-amine
CID 170656714

Frequently Asked Questions

What is the IUPAC name of 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline?
The IUPAC name of 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline (CID 160531607) is 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline.
What is the SMILES notation for 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline?
The canonical SMILES for 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline is CC1(C)c2ccccc2N(c2cc(N(c3ccc(-c4ccncc4)cc3)c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cc(N3c4ccccc4C(C)(C)c4ccccc43)c2)c2ccccc21.Cc1cc2c3cc(C)c(C)cc3n(-c3cc(N(c4ccc(-c5ccncc5)cc4)c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)cc(-n4c5cc(C)c(C)cc5c5cc(C)c(C)cc54)c3)c2cc1C.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(N(c4ccc(-c5ccncc5)cc4)c4cc(N5c6ccccc6Oc6ccccc65)cc(N5c6ccccc6Oc6ccccc65)c4)cc3)n2)cc1.
What is the InChIKey of 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline?
The InChIKey is QVPQQXHIFIULSC-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H57N7.C68H53N7.C62H41N7O2/c1-42-31-60-61-32-43(2)47(6)36-65(61)76(64(60)35-46(42)5)58-39-57(40-59(41-58)77-66-37-48(7)44(3)33-62(66)63-34-45(4)49(8)38-67(63)77)75(55-23-19-50(20-24-55)51-27-29-71-30-28-51)56-25-21-54(22-26-56)70-73-68(52-15-11-9-12-16-52)72-69(74-70)53-17-13-10-14-18-53;1-67(2)56-23-11-15-27-60(56)74(61-28-16-12-24-57(61)67)54-43-53(44-55(45-54)75-62-29-17-13-25-58(62)68(3,4)59-26-14-18-30-63(59)75)73(51-35-31-46(32-36-51)47-39-41-69-42-40-47)52-37-33-50(34-38-52)66-71-64(48-19-7-5-8-20-48)70-65(72-66)49-21-9-6-10-22-49;1-3-15-44(16-4-1)60-64-61(45-17-5-2-6-18-45)66-62(65-60)46-29-33-48(34-30-46)67(47-31-27-42(28-32-47)43-35-37-63-38-36-43)49-39-50(68-52-19-7-11-23-56(52)70-57-24-12-8-20-53(57)68)41-51(40-49)69-54-21-9-13-25-58(54)71-59-26-14-10-22-55(59)69/h9-41H,1-8H3;5-45H,1-4H3;1-41H.
What are the key properties of 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline?
3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline has a molecular weight of 2880.55 g/mol, XLogP of 52.24, 27 rotatable bonds, 0 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-bis(9,9-dimethylacridin-10-yl)-N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3,5-di(phenoxazin-10-yl)-N-(4-pyridin-4-ylphenyl)aniline;N-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-N-(4-pyridin-4-ylphenyl)-3,5-bis(2,3,6,7-tetramethylcarbazol-9-yl)aniline is sourced from PubChem (CID 160531607), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).